Company page

Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. The company has a market capitalization of approximately $15.2 million. Pasithea focuses on developing innovative therapies, although specific details about its products or services are not provided.

KTTA:NASDAQUpdated September 11, 2026
Pasithea Therapeutics Corp. logo
Ticker
KTTA:NASDAQ
Asset type
Stock
Market cap
$17.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD